The NIAID Leadership Vacuum: How a Headless Institute Struggles as Ebola resurfaces
A critical look at the NIAID's lack of leadership during the current Ebola spread and the lasting impact of Anthony Fauci's departure.
A critical look at the NIAID's lack of leadership during the current Ebola spread and the lasting impact of Anthony Fauci's departure.
Protests in Kenya and diplomatic friction in Zambia reveal a growing backlash against the US 'America First Global Health Strategy' and its link to critical minerals.
The National Institute of Allergy and Infectious Diseases (NIAID) remains without a permanent director as new Ebola concerns rise, raising questions about US pandemic readiness.
Alphabet's Debug program is deploying 32 million Wolbachia-infected male mosquitoes to combat disease-carrying populations in Florida and California.
CEPI has allocated $50 million to Moderna to accelerate an mRNA vaccine for the Bundibugyo ebolavirus as an outbreak surges in the DRC.
The NIAID, once led by Anthony Fauci, faces a critical leadership void as new Ebola outbreaks emerge, raising questions about the US's readiness for the next pandemic.
The Trump administration's plan to weaken coal ash monitoring and groundwater protections faces fierce opposition from environmental lawyers and neurobiological researchers.
Environmental advocates and health researchers challenge the EPA's move to weaken coal ash regulations, citing risks to groundwater and child neurodevelopment.
The EPA's proposed deregulation of coal ash residue faces fierce opposition from environmentalists and health researchers over groundwater safety and child neurobiology.
From 18th-century smallpox inoculation to modern mandates, explore the recurring patterns of vaccine skepticism and the historical context of public health battles.